High-Risk Groups for Multiple Myeloma: Prevention and Management - Oncology

Share to:

Regarding high-risk groups for multiple myeloma?


Hello Director Lai,
Last year, my father was informed that he is in a high-risk group for multiple myeloma, which was discovered through blood test results.
The doctor advised that he should have blood tests every three months to check for any abnormal indices.
My question is, based on my understanding of this disease, even though we know he is in a high-risk group, there seems to be no way to take adequate preventive measures or improve his condition.
I would like to know if, aside from regular monitoring, you have any recommendations regarding lifestyle changes, diet, or other medications.
Given that we are already aware of his high-risk status, it feels challenging to actively confront the treatment of this disease.
Additionally, I would like to inquire if there are any more effective foreign medications beyond those covered by health insurance that I could research.
Facing this known reality, I hope to be better prepared.
Thank you for your response, Director Lai.

Shen Sir, 30~39 year old female. Ask Date: 2016/03/10

Dr. Lai Yicheng reply Oncology


Mr.
Shen: In response to your inquiry regarding your father's high-risk status for multiple myeloma, I would like to provide the following information:
1.
It is generally recognized that risk factors for multiple myeloma include: age, gender (male > female), race (Black > White), exposure to radiation, family history of multiple myeloma, obesity, and a history of monoclonal gammopathy.
Currently, the medical community does not have a clear understanding of how to prevent multiple myeloma.
Unlike the well-established prevention methods for lung cancer through smoking cessation, cervical cancer through vaccination, and hepatitis B and liver cancer through vaccination, the mechanisms for preventing multiple myeloma remain unclear.
2.
Regarding treatment: The treatment approaches for multiple myeloma in Taiwan are in line with international standards.
First-line therapy primarily involves traditional chemotherapy combined with Thalidomide.
If treatment fails, second-line options may include stem cell transplantation or targeted therapy (such as Velcade).
Changhua Hospital is concerned about you.
Director Lai Yi-Cheng

Reply Date: 2016/03/10

More Info


Understanding high-risk groups for multiple myeloma (MM) is crucial for both patients and their families, especially when it comes to prevention and management strategies. Multiple myeloma is a type of blood cancer that affects plasma cells, which are a kind of white blood cell responsible for producing antibodies. Identifying individuals at high risk for developing this disease can help in monitoring and potentially mitigating its impact.


Risk Factors and Monitoring
As noted, certain risk factors are associated with multiple myeloma, including age, gender (more common in men), race (higher incidence in African Americans), family history, obesity, and previous conditions like monoclonal gammopathy of undetermined significance (MGUS). While knowing these risk factors is essential, it is equally important to understand that there is currently no definitive way to prevent multiple myeloma. Unlike other cancers where preventive measures are well-defined (such as smoking cessation for lung cancer), the prevention mechanisms for MM remain unclear.

Regular monitoring is vital for those identified as high-risk. Your father's physician's recommendation for blood tests every three months is a standard approach to detect any abnormalities early. These tests typically measure levels of certain proteins (like M-protein) and assess kidney function, among other parameters.


Lifestyle and Dietary Recommendations
While there is no guaranteed way to prevent multiple myeloma, certain lifestyle modifications may help improve overall health and potentially reduce the risk of developing various diseases, including cancers:
1. Diet: A balanced diet rich in fruits, vegetables, whole grains, and lean proteins can support overall health. Some studies suggest that diets high in antioxidants may help combat oxidative stress, which is linked to cancer development. Foods rich in omega-3 fatty acids (like fish) and those high in fiber may also be beneficial.

2. Physical Activity: Regular exercise is crucial for maintaining a healthy weight and improving overall well-being. It can also help reduce stress, which is important for immune function.

3. Avoiding Tobacco and Limiting Alcohol: Smoking is a known risk factor for many cancers, and excessive alcohol consumption can also have detrimental effects on health. Avoiding these substances can be a proactive step.

4. Stress Management: Chronic stress can negatively impact the immune system. Techniques such as mindfulness, yoga, and meditation can be beneficial.


Medications and Treatment Options
Regarding medications, the first-line treatment for multiple myeloma typically includes a combination of traditional chemotherapy and newer agents like Thalidomide. If treatment fails, options such as stem cell transplantation or targeted therapies (like Bortezomib) may be considered.
As for medications not covered by insurance, it is essential to consult with your father's healthcare provider. They can provide information on clinical trials or newer therapies that may be available. Researching reputable sources and discussing these options with a healthcare professional can help you make informed decisions.


Conclusion
While being classified as a high-risk group for multiple myeloma can be daunting, proactive monitoring and lifestyle modifications can help manage health effectively. Regular consultations with healthcare providers, adherence to monitoring schedules, and maintaining a healthy lifestyle are essential components of managing the risk. It’s also important to stay informed about new treatment options and research developments in the field of multiple myeloma. Your father's healthcare team can be a valuable resource in navigating these challenges and making informed decisions about his health.

Similar Q&A

Understanding Multiple Myeloma: Risks and Treatment Options Explained

What is multiple myeloma? What are its dangers? What treatment options are available? <Stage III> Thank you!


Dr. Yang Youhua reply Oncology
Multiple myeloma is a malignancy characterized by the uncontrolled proliferation of plasma cells in the bone marrow, leading to the excessive production of monoclonal immunoglobulin. Cancer cells secrete cytokines that stimulate osteoclasts, resulting in bone pain, multiple fract...

[Read More] Understanding Multiple Myeloma: Risks and Treatment Options Explained


Understanding Monoclonal Gammopathy: Risks and Management Strategies

My mother was informed during a blood test at Taipei Veterans General Hospital that her IgG levels were elevated (first test 1685, second test 1698) and her Kappa/Lambda ratio (approximately 20 in the first test, about 22 in the second test). The doctor, concerned about the first...


Dr. Hu Ziren reply Oncology
This condition cannot be prevented; subsequent follow-up is more important. If concerned, it is advisable to return for a check-up every six months. If any of the following situations occur, it is recommended to schedule an earlier appointment: worsening kidney function (decrease...

[Read More] Understanding Monoclonal Gammopathy: Risks and Management Strategies


Understanding Multiple Myeloma: Concerns on Cancer Markers and Treatment Options

Hello Doctor: My mother previously underwent a bone marrow biopsy, which revealed multiple myeloma with cancer markers exceeding 10,000. I have a few questions: 1. Are cancer markers standardized, and is this level considered very serious? (It seems to be related to immunoglobuli...


Dr. Fan Sheng reply Oncology
Dear Mr. Hsieh: 1. Different types of cancer have their specific tumor markers. Immunoglobulins can be used to assess the condition of multiple myeloma, and values in the tens of thousands indicate a severe situation. 2. Combining Venclexta with other medications in the first...

[Read More] Understanding Multiple Myeloma: Concerns on Cancer Markers and Treatment Options


Managing Suspected Multiple Myeloma: Key Insights and Recommendations

Hello, my father is 64 years old. Recently, a blood test revealed a hemoglobin level of 9.4 gm/dL. Despite multiple blood transfusions, his hemoglobin remains below 10 gm/dL, prompting further examination. The results showed the following: Na=132 mmol/L, IgG=3292 gm/dL, HbA1c=6.9...


Dr. Chen Yunfang reply Oncology
Hello: 1. Have you confirmed a diagnosis of multiple myeloma? So you received a major illness certificate? Based on your statement, it is impossible because a bone marrow aspiration has not been performed! Without a bone marrow aspiration, a diagnosis of myeloma cannot be made. A...

[Read More] Managing Suspected Multiple Myeloma: Key Insights and Recommendations


Related FAQ

Multiple Myeloma

(Oncology)

Thalassemia

(Oncology)

Leukemia

(Oncology)

Aplastic Anemia

(Oncology)

Thrombocytosis

(Oncology)

Cancer Screening

(Oncology)

Melanoma

(Oncology)

Lymphadenopathy

(Oncology)

Oral Cancer

(Oncology)

Pancreatic Cancer

(Oncology)